Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
abnormal, abobotulinumtoxinA, acetate, acetylsalicylic, acnefree, actinic, acuminate, adjournment, adjudication, advantage, AK, Alkem, ambi, amino, Anacor, andolex, anterior, antibiotic, anticipatorily, antigrippin, antimycotic, Antonio, arestin, Ariz, Asian, Atlantic, Austria, bacterial, balding, BB, bench, Bermuda, Biopharm, bioresorbable, Black, boron, Box, Boxed, Cadila, caffeine, caladryl, cefzil, cellulose, Ch, chemistry, China, choroidal, CIS, Citizen, classic, CMS, Cobalt, CODM, commerce, Commonwealth, contributor, corn, cortaid, DEA, Del, denial, dentistry, depth, dermaglow, destination, device, discrimination, distinct, duracef, duty, dysport, EEOC, effectuate, Eisai, emervel, enjoin, evolution, exam, eye, EZ, farmer, FDCA, female, fibrillation, filler, flecainide, floor, fluocinonide, FOB, gastro, gender, Gerot, glabellar, glaucoma, Graceway, HANA, Hanson, HCl, HIPAA, hydroxypropyl, hygiene, hyperpigmentation, imidazole, imiquimod, indemnity, inducing, insert, interference, interpreted, intraocular, Ipsen, isolation, Isotretinoine, Jason, Jelfa, joinder, JSC, JV, JVs, Kazakhstan, KLOX, Korea, Lannach, laser, leaky, lincosamide, lip, Lithuanian, Luliconazole, Luxembourg, Lymphoma, Maker, Maricopa, megace, mentioned, Merlin, migrated, minocycline, molecule, Monster, municipal, muscle, MXN, myopia, necessitated, neovascularization, neurotoxin, Nominee, norgesic, null, obviate, ocular, offensive, ophthalmologist, orapharma, orphenadrine, paracetamol, pathologic, payout, pegaptanib, pen, Penlac, perianal, periodontal, perlane, Pharmascience, pholtex, photoaging, photodynamic, planing, PLN, pocket, podiatry, Portability, prebiotic, Produkt, pruritic, Pure, Pvt, QLT, realistically, red, referencing, referral, refrain, remuneration, reorganization, reprice, Repriced, repricing, rescission, restylane, retinoid, ronald, root, ROW, run, Ryan, sage, salicylic, scaling, scalp, seborrheic, shower, Sidmak, signatory, slightly, Soft, solar, solodyn, solution, Squibb, SRP, Stiefel, streamline, student, subfoveal, subgingival, Sunshine, supposedly, supraventricular, Swint, tachycardia, Taiwan, tambocor, targretin, teeth, tension, texture, therewith, thrombo, timolol, timoptic, tinea, Topco, transparency, treatement, unasserted, underwriting, unpatented, USPTO, Uzbekistan, VELTIN, VELTINTM, verteporfin, vigorously, vii, visudyne, vivo, void, VPI, Weldon, whey, White, whitening, withdrew, ziana, zyclara
Removed:
ACADIA, accept, Adalat, Alzheimer, Amgen, analyzed, Andrx, attract, bed, bid, bioequivalent, BNY, bringing, broader, buyer, calculating, Carolina, CC, cell, Chantilly, Circuit, community, complied, complying, comprising, concerted, conclude, Continuance, Convection, counterpart, CRA, CRD, cycle, delayed, delivering, difficult, Directorate, Dorado, Dublin, Durham, dyskinesia, Edgar, ejaculation, Engleman, enhanced, exploit, fit, forced, genericization, globally, headcount, implementation, improved, imputed, intention, internationally, involving, isomer, la, leased, leasehold, leave, linked, Manitoba, medicinal, Minnesota, mitigation, monopolization, moot, Nevada, night, nil, Nova, observed, opening, opposed, Paddock, permitting, premature, President, Prestwick, Procardia, procedure, proportional, quantity, rationalize, reacquired, reaction, recognizing, reformulation, relationship, residual, safe, Santhera, Scotia, Sherman, shutdown, Sofinnova, SOX, spike, SR, Steinbach, stronger, sun, Syndrome, tendered, Tennessee, theCanada, theCompetition, theIncome, theInvestment, Therapeutix, TITRADOSE, Tourette, TPD, track, tramadol, unchanged, underway, unlisted, unsuccessful, unusual, vacating, vaseretic, vasotec, Virginia, virtually, Wisconsin, withdrawn, XR, zyban
Filing tables
Filing exhibits
Related press release
BHC similar filings
Filing view
External links
Exhibit 23.2
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements on Form S-4 (No. 333-168254) and Form S-8 (Nos. 333-92229, 333-138697, 333-168629, 333-168254, 333-176205) of Valeant Pharmaceuticals International, Inc. of our report dated February 29, 2012 (except for Note 26 which contains restated segment information to reflect a new management structure, for which the date is February 28, 2013) relating to the consolidated financial statements and financial statement schedule of Valeant Pharmaceuticals International, Inc., which appears in this Form 10-K.
/s/ PricewaterhouseCoopers LLP | ||
Toronto, Canada February 28, 2013 | Chartered Accountants Licensed Public Accountants |